Quality Management

Materials for clinical trials must be fit for their intended use

Pharmaceutical products including materials for clinical trials must be fit for their intended use, comply with the relevant requirements and must not place patients at risk due to inadequate safety, quality or efficacy.

To achieve this quality objective in a reliable manner, the team at the GBA Group has implemented a comprehensive quality management system in which all quality assurance measures are based on Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP).